| NCT Number | NCT07126496 |
| Lead Sponsor | Mayo Clinic
Collaborators: National Cancer Institute (NCI) |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 2,000 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2027-08-31 (estimated) |
| Study Completion | 2027-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-11 |